- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE AGN) as its February 2010 “Stock to Study” and C. R. Bard, Inc. (NYSE BCR) as its February 2010 “Undervalued Stock” for investors’ informational and educational use.
“The committee chose Allergan because of growth opportunities involving its flagship drug Botox and other products as well as a reasonable current valuation,” said Adam Ritt, editor of BetterInvesting Magazine. “For the Undervalued selection, the committee believes C.R. Bard’s business should benefit when hospitals begin restocking supplies.” Check BetterInvesting Magazine’s February issue for more details about these selections.
Committee members are Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; Kenneth S. Janke, Sr.; Walter J. Kirchberger, CFA; Marisa Lenhard, CFA; and Donald T. Spindel, CFA.
As stated, the BetterInvesting committee’s Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases. For more information about investment education tools available to individual investors and investment clubs visit www.betterinvesting.org.
Follow us on Twitter and Facebook.
BetterInvesting Magazine is published monthly by BetterInvesting.
BetterInvesting is the brand identity of the National Association of Investors Corporation, a national, nonprofit association with members consisting of individual investors and investment clubs. Founded in 1951 and with headquarters in Madison Heights, Mich., BetterInvesting is considered the voice of the individual investor, as well as the pioneer of the modern investment club movement. BetterInvesting is dedicated to providing a sound program of investment education and information to help its members become successful long-term, lifetime investors.